In this episode of the Psychedelic Spotlight Podcast, we delve deep into PSYC's latest developments and future directions. CEO David Flores shares an in-depth update, shedding light on the company’s strategic milestones and the broader impact on the psychedelic sector.

On this episode of the Psychedelic Spotlight Podcast, we dive into a critical discussion sparked by the recent news surrounding Matthew Perry’s passing and its consequent impact on public perception of ketamine and other psychedelics used in therapeutic settings.

In this episode of the Psychedelic Spotlight Podcast, we spotlight the unique and unsuspecting intersection where psychedelics and real estate are beginning to converge as the psychedelic industry moves closer to mass adoption.

On this episode of the Psychedelic Spotlight Podcast, our host David Flores catches up with former Philadelphia Flyer and NHL enforcer, Riley Cote who in recent years has become one of the most prominent and outspoken advocates for psychedelics and psychedelic-assisted therapy through his work with the Wake Network and RileyCote.com.

In this episode, David and Kevin Colley discuss Kevin's remarkable journey from a career-ending NHL injury to profound healing and self-discovery through psychedelic therapy, alongside a conversation on masculinity in sports and the importance of seeking help when facing emotional challenges.

We delve into the world of psychedelic medicine with Hadas Alterman, Director of Government Affairs at APPA, where we explore their mission to revolutionize healthcare, the groundbreaking professional practice guidelines for psychedelic therapy, and their strategic partnership with The Daschle Group, all aimed at advancing the integration of psychedelics into mainstream healthcare.

In this captivating episode, David engages in a thought-provoking conversation with none other than Joshua White, the visionary CEO behind the Fireside Project. This groundbreaking initiative has ushered in a new era of support and safety within the realm of psychedelics, as it introduces the world's first real-time psychedelic peer support line.

In this episode, David Flores engages in a conversation with Brett Waters, Esq., the Co-Founder and Executive Director of Reason for Hope, to explore policy and legal reforms aimed at realizing safe, ethical, and affordable access to psychedelic-assisted therapy.

In this episode, David Flores delves into the fascinating realm of psilocybin cultivation, innovation, and exploration with the co-founding managing partners of Rose Hill, a pioneering company based in Jamaica.

In this episode, David talks with Sherry Rais of Enthea to discuss Enthea’s very unique objective of helping employers optimize happiness and health within their workplace by integrating ketamine therapy as an add-on to their existing employee health benefit programs.